Artemisia Absinthium PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
84929-19-1
Molecular formula
Not available
Molecular weight
Not available
Drug class
Botanical herbal drugwormwood (Artemisia absinthium) bitter herb
Mechanism of action
Contains bitter sesquiterpene lactones and volatile oil constituents. Traditional use is based on bitter-taste stimulation of digestive secretions; no single defined molecular target is established.
Indications / reported uses
Traditional herbal use for temporary loss of appetite and mild dyspeptic complaints in adults in products meeting applicable herbal monograph requirements; not an authorised anti-parasitic treatment by default
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Artemisia Absinthium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Artemisia Absinthium Permitted Daily Exposure (PDE) report (the Artemisia Absinthium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Artemisia Absinthium Occupational Exposure Limit (OEL) report (the Artemisia Absinthium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.